首頁 > 市場調查報告書 > 製藥

再生醫學細胞療法

市場調查報告書

商品編碼

1526033

細胞治療生物製造：全球市場

Cell Therapy Biomanufacturing: Global Markets

出版日期: 2024年08月01日 | 出版商:

BCC Research | 英文 112 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

全球細胞治療生物製造市場規模預計將從 2024 年的 97 億美元增至 2029年終的 167 億美元，預測期內複合年成長率為 11.5%。

治療藥物類型產業預計將從 2024 年的 53 億美元增至 2029 年底的86 億美元，複合年成長率為 10.2%。此外，細胞來源產業預計將從 2024 年的 44 億美元成長到 2029年終的81 億美元，複合年成長率為 13.0%。

本報告調查了全球細胞治療生物製造市場，並提供了市場概況、市場影響因素和市場機會分析、新興技術和技術發展趨勢、市場規模趨勢和預測、各個細分市場和地區的詳細分析、競爭格局。

概述
市場促進因素
慢性病和退化性疾病盛行率上升
加大研發投入
生物加工技術進步
擴大細胞治療藥物生產基礎設施
市場限制因素
製造複雜性和成本
供應鏈問題
產品穩定性和保存期限
市場機會
新的治療應用
以病人為中心的醫療保健模式

第4章法律規範

監管機構
調控途徑
品質保證
製造標準
為世界和諧努力

第5章新興技術與發展

最新技術/主要進展
先進的細胞培養系統
基因組編輯技術
生物程序創新
細胞分選和精製
自動化和機器人技術
資料分析與機器學習
組織工程和類器官技術
照護現場製造

第6章市場區隔分析

主要市場趨勢
細分細分
市場分析：依產品類型
治療藥物類型
細胞來源
市場分析：依應用分類
骨骼肌修復
骨修復
癌症
心血管疾病
神經系統疾病
其他
地域分佈
市場分析：按地區
北美洲
歐洲
亞太地區
其他地區

第7章競爭訊息

世界公司排名
戰略分析
併購和創投

第 8 章細胞治療生物製造的永續性：ESG 視角

對環境造成的影響
供應鏈永續性
社會責任感
企業管治
產品生命週期管理
能源和水
回收
工藝設計和材料
回收一次性塑膠
工作環境

第9章附錄

調查方法
來源
縮寫詞
公司簡介
BIOSENIC
BRISTOL-MYERS SQUIBB CO.
DANAHER CORP.
IOVANCE BIOTHERAPEUTICS INC.
LISATA THERAPEUTICS
LONZA
MERCK KGAA
THERMO FISHER SCIENTIFIC INC.

簡介目錄圖表

Product Code: BIO211B

The global market for cell therapy biomanufacturing is expected to grow from $9.7 billion in 2024 and is projected to reach $16.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.5% during the forecast period of 2024 to 2029.

The global market for cell therapy biomanufacturing for type of therapy is expected to grow from $5.3 billion in 2024 and is projected to reach $8.6 billion by the end of 2029, at a CAGR of 10.2% during the forecast period of 2024 to 2029.

The global market for cell therapy biomanufacturing for sources of cells is expected to grow from $4.4 billion in 2024 and is projected to reach $8.1 billion by the end of 2029, at a CAGR of 13.0% during the forecast period of 2024 to 2029.

Report Scope:

This report discusses the key trends shaping the global cell therapy biomanufacturing market, exploring factors that drive or hinder growth while providing valuable insights for stakeholders and potential newcomers. It examines R&D investment, heightened competition, and emerging technologies steering market dynamics. Moreover, the report assesses how advancements, product launches, and governmental initiatives impact future market trajectories. It also scrutinizes corporate actions like mergers, acquisitions, and partnerships. Additionally, the report evaluates the efficacy of various strategies in light of evolving technologies, intensifying competition, and shifting consumer demands.

Report Includes:

17 data tables and 25 additional tables
Analysis of the global markets for cell therapy biomanufacturing
Analyses of global market trends, with market revenue data from 2022, estimates for 2023, forecasts for 2024 and projected CAGRs through 2029
Estimates of the current market size and revenue prospects, along with a market share analysis by product type, application, end user and region
Facts and figures pertaining to the market dynamics, technological advances, product launches, regulatory scenarios, and the expected impact of macroeconomic factors
An analysis of patents and emerging technologies
Overview of sustainability trends and ESG developments in the industry, with a focus on consumer attitudes, companies' ESG score rankings and their ESG practices

An analysis of the industry structure, including companies' market shares, merger and acquisition activity, and venture funding

Profiles of the leading companies, including Thermo Fisher Scientific Inc., Bristol-Myers Squibb Co., Lonza, Merck KGaA, andBioSenic SA

Chapter 1 Executive Summary

Market Outlook
Scope of Report
Market Summary

Chapter 2 Market Overview

Overview
Cell Therapy
Stem Cell Transplantation
Stem Cell Biomanufacturing
Stem Cell Classification Based on Source
Stem Cell Classification Based on Ability to Differentiate
Uses of Stem Cells
Application of Stem Cells
Mechanism of Cell Therapy
Delivery Method of Cell-Based Therapy

Chapter 3 Market Dynamics

Overview
Market Drivers
Rising Prevalence of Chronic and Degenerative Diseases
Growing Investment in R&D
Technological Advancements in Bioprocessing
Expansion of Cell Therapy Manufacturing Infrastructure
Market Restraints
Complexity and Cost of Manufacturing
Supply Chain Issues
Product Stability and Shelf Life
Market Opportunities
Emerging Therapeutic Applications
Patient-Centric Healthcare Models

Chapter 4 Regulatory Structure

Regulatory Authorities
Regulatory Pathways
Quality Assurance
Manufacturing Standards
Global Harmonization Efforts

Chapter 5 Emerging Technologies and Developments

Newest Technologies/Key Developments
Advanced Cell Culture Systems
Genome Editing Technologies
Bioprocessing Innovation
Cell Sorting and Purification
Automation and Robotics
Data Analytics and Machine Learning
Tissue Engineering and Organoid Technologies
Point-of-Care Manufacturing

Chapter 6 Market Segmentation Analysis

Key Market Trends
Segmentation Breakdown
Market Analysis, by Product Type
Type of Therapy
Source of Cells
Market Analysis, by Application
Skeletal Muscle Repair
Bone Repair
Cancer
Cardiovascular Diseases
Neurological Disorders
Other Diseases
Geographic Breakdown
Market Analysis, by Region
North America
Europe
Asia-Pacific
Rest of the World

Chapter 7 Competitive Intelligence

Global Company Ranking
Strategic Analysis
M&A and Venture Funding

Chapter 8 Sustainability in Cell Therapy Biomanufacturing: An ESG Perspective

Environmental Impact
Supply Chain Sustainability
Social Responsibility
Corporate Governance
Product Lifecycle Management
Energy and Water
Recycling
Process Design and Materials
Recycling Single-Use Plastics
Work Environment

Chapter 9 Appendix

Methodology
Sources
Acronyms
Company Profiles
BIOSENIC
BRISTOL-MYERS SQUIBB CO.
DANAHER CORP.
IOVANCE BIOTHERAPEUTICS INC.
LISATA THERAPEUTICS
LONZA
MERCK KGAA
THERMO FISHER SCIENTIFIC INC.

簡介目錄圖表

List of Tables

Summary Table A : Global Market for Cell Therapy Biomanufacturing, by Product Type, Through 2029
Summary Table B : Global Market for Cell Therapy Biomanufacturing, by Application, Through 2029
Table 1 : Global Market for Cell Therapy Biomanufacturing, Through 2029
Table 2 : Global Market for Cell Therapy Biomanufacturing, by Product Type, Through 2029
Table 3 : Global Market for Cell Therapy Biomanufacturing, by Application, Through 2029
Table 4 : Global Market for Cell Therapy Biomanufacturing, by Region, Through 2029
Table 5 : North American Market for Cell Therapy Biomanufacturing, by Country, Through 2029
Table 6 : European Market for Cell Therapy Biomanufacturing, by Country, Through 2029
Table 7 : Asia-Pacific Market for Cell Therapy Biomanufacturing, by Country, Through 2029
Table 8 : RoW Market for Cell Therapy Biomanufacturing, by Country, Through 2029
Table 9 : Global Market Rankings of Cell Therapy Biomanufacturing, 2023
Table 10 : Report Sources
Table 11 : Acronyms Used in Cell Therapy Biomanufacturing Market
Table 12 : BioSenic: Company Snapshot
Table 13 : BioSenic: Financial Performance, 2022 and 2023
Table 14 : BioSenic: Product Portfolio
Table 15 : Bristol-Myers Squibb Co.: Company Snapshot
Table 16 : Bristol-Myers Squibb Co.: Financial Performance, FY 2022 and 2023
Table 17 : Bristol-Myers Squibb Co.: Product Portfolio
Table 18 : Bristol-Myers Squibb Co.: News/Key Developments, 2024
Table 19 : Danaher Corp.: Company Snapshot
Table 20 : Danaher Corp.: Financial Performance, FY 2022 and 2023
Table 21 : Danaher Corp.: Product Portfolio
Table 22 : Danaher Corp.: News/Key Developments, 2023
Table 23 : Iovance Biotherapeutics Inc.: Company Snapshot
Table 24 : Iovance Biotherapeutics Inc.: Financial Performance, FY 2022 and 2023
Table 25 : Iovance Biotherapeutics Inc: Product Portfolio
Table 26 : Iovance Biotherapeutics Inc.: News/Key Developments, 2023
Table 27 : Lisata Therapeutics: Company Snapshot
Table 28 : Lisata Therapeutics: Financial Performance, FY 2022 and 2023
Table 29 : Lisata Therapeutics: Product Portfolio
Table 30 : Lisata Therapeutics: News/Key Developments, 2022
Table 31 : Lonza: Company Snapshot
Table 32 : Lonza Financial Performance, FY 2022 and 2023
Table 33 : Lonza: Product Portfolio
Table 34 : Lonza: News/Key Developments, 2023
Table 35 : Merck KGaA: Company Snapshot
Table 36 : Merck KGaA: Financial Performance, FY 2022 and 2023
Table 37 : Merck KgaA: Product Portfolio
Table 38 : Thermo Fisher Scientific Inc.: Company Snapshot
Table 39 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
Table 40 : Thermo Fisher Scientific Inc: Product Portfolio
Table 41 : Thermo Fisher Scientific Inc: News/Key Developments, 2023

List of Figures

Summary Figure A : Global Market for Cell Therapy Biomanufacturing, by Product Type, 2021-2029
Summary Figure B : Global Market for Cell Therapy Biomanufacturing, by Application, 2021-2029
Figure 1 : Market Dynamics of Cell Therapy Biomanufacturing
Figure 2 : Global Market Shares of Cell Therapy Biomanufacturing, by Product Type, 2023
Figure 3 : Global Market Shares of Cell Therapy Biomanufacturing, by Application, 2023
Figure 4 : Global Market Shares of Cell Therapy Biomanufacturing, by Region, 2023
Figure 5 : North American Market Shares of Cell Therapy Biomanufacturing, by Country, 2023
Figure 6 : European Market Shares of Cell Therapy Biomanufacturing, by Country, 2023
Figure 7 : Asia-Pacific Market Shares of Cell Therapy Biomanufacturing, by Country, 2023
Figure 8 : RoW Market Shares of Cell Therapy Biomanufacturing, by Country, 2023
Figure 9 : Bristol-Myers Squibb Co.: Revenue Share, by Country/Region, FY 2023
Figure 10 : Danaher Corp.: Revenue Share, by Business Unit, FY 2023
Figure 11 : Danaher Corp.: Revenue Share, by Country/Region, FY 2023
Figure 12 : Lonza: Revenue Share, by Business Unit, FY 2023
Figure 13 : Lonza: Revenue Share, by Country/Region, FY 2023
Figure 14 : Merck KGaA: Revenue Share, by Business Unit, FY 2023
Figure 15 : Merck KgaA: Revenue Share, by Country/Region, FY 2023
Figure 16 : Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, 2023
Figure 17 : Thermo Fisher Scientific Inc.: Revenue Share, by Country/Region, 2023